These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32929931)
1. [Complex treatment of a patient with neurofibromatosis type 2]. Rynda AY; Olyushin VE; Rostovtsev DM; Zabrodskaya YM Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):98-104. PubMed ID: 32929931 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2. Sun S; Liu A J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947 [TBL] [Abstract][Full Text] [Related]
3. Multiple cranial nerve schwannomas and meningiomas as a hallmark sign of neurofibromatosis type 2 in a child. Halefoğlu AM Turk J Pediatr; 2018; 60(1):107-110. PubMed ID: 30102490 [TBL] [Abstract][Full Text] [Related]
4. Management of multiple tumors in neurofibromatosis type 2 patients. Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178 [TBL] [Abstract][Full Text] [Related]
5. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128 [TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis type 2. Slattery WH Otolaryngol Clin North Am; 2015 Jun; 48(3):443-60. PubMed ID: 26043141 [TBL] [Abstract][Full Text] [Related]
7. Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the Basenach E; Förster A; Raab P; Alzein S; Schmidt G; Krauss JK; Schlegelberger B; Heidenreich F; Auber B; Hartmann C; Wiese B; Weber RG Clin Neuropathol; 2022; 41(4):162-167. PubMed ID: 35445657 [TBL] [Abstract][Full Text] [Related]
8. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2. Fisher LM; Doherty JK; Lev MH; Slattery WH Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434 [TBL] [Abstract][Full Text] [Related]
9. Growth Dynamics of Intracranial Tumors in Patients with Neurofibromatosis Type 2. Lawson McLean AC; Rosahl SK World Neurosurg; 2017 Feb; 98():152-161. PubMed ID: 27777160 [TBL] [Abstract][Full Text] [Related]
10. Unusual case of multiple cellular and malignant schwannomas of the cranial and spinal nerves. Suresh TN; Mahadevan A; Chandrashekhar Sagar B; Santosh V; Yasha TC; Shankar SK Clin Neuropathol; 2003; 22(1):23-9. PubMed ID: 12617190 [TBL] [Abstract][Full Text] [Related]
11. Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2. Cunliffe IA; Moffat DA; Hardy DG; Moore AT Br J Ophthalmol; 1992 May; 76(5):310-2. PubMed ID: 1390517 [TBL] [Abstract][Full Text] [Related]
12. Contiguous conventional and plexiform schwannomas. Report of two cases. White JB; Scheithauer BW; Amrami KK; Babovic-Vuksanovic D; Spinner RJ J Neurosurg; 2006 Feb; 104(2):319-24. PubMed ID: 16509508 [TBL] [Abstract][Full Text] [Related]
13. [Diagnostic image (252). A woman with complaints of tinnitus, hearing loss and headache]. te Lintelo MP; Koehler PJ Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2565. PubMed ID: 16320667 [TBL] [Abstract][Full Text] [Related]
14. The neurofibromatosis type 2 gene is inactivated in schwannomas. Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas. Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients. Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342 [TBL] [Abstract][Full Text] [Related]
19. The Role of Neuro-Ophthalmologists in the Care of Patients With Neurofibromatosis Type 2. Landau K J Neuroophthalmol; 2020 Sep; 40 Suppl 1():S51-S56. PubMed ID: 32796346 [TBL] [Abstract][Full Text] [Related]
20. Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case series. Alanin MC; Klausen C; Caye-Thomasen P; Thomsen C; Fugleholm K; Poulsgaard L; Lassen U; Mau-Sorensen M; Hofland KF Int J Neurosci; 2016 Nov; 126(11):1002-6. PubMed ID: 26365467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]